BioCryst Pharmaceuticals BCRX Product sales, net — Total revenues

Similar metrics at other companies

TARSProduct sales, net — Total revenues

$145.39M+85.6%

AUPHNet product sales — Revenue

$73.56M+22.7%

TVTXTotal net product sales — Total Revenue

$124.49M+64.1%

MIRMProduct sales, net — Product sales, net

$159.88M+43.3%

SUPNNet product sales — Total revenues

$150.75M+6.2%

CRNXProduct revenue, net — Total Revenue

$10.31M—

Questions, answered.

What is BioCryst Pharmaceuticals's product sales, net — total revenues?

BioCryst Pharmaceuticals (BCRX) reported product sales, net — total revenues of $151.4M in Q1 2026.

How has BioCryst Pharmaceuticals's product sales, net — total revenues changed year-over-year?

BioCryst Pharmaceuticals's product sales, net — total revenues increased by 5.3% year-over-year, from $143.79M to $151.4M.

What is the long-term trend for BioCryst Pharmaceuticals's product sales, net — total revenues?

Over 4 years (2021 to 2025), BioCryst Pharmaceuticals's product sales, net — total revenues has grown at a 46.2% compound annual growth rate (CAGR), from $136.35M to $623.15M.

What does product sales, net — total revenues mean?

This metric represents the total net revenue generated from the sale of pharmaceutical products within a specific business segment. It reflects the company's ability to commercialize its drug portfolio and serves as a primary indicator of market adoption for its therapeutic offerings. This figure is calculated after accounting for returns, discounts, and allowances associated with product distribution.